Affymax, Inc. (AFFY)
OTCMKTS · Delayed Price · Currency is USD
0.0416
+0.0399 (2,347.06%)
At close: Oct 9, 2026
Affymax Market Cap
Affymax has a market cap or net worth of $3.1 million as of October 16, 2026. It is the 46,666th most valuable company in the world and the 6,254th biggest in the United States. Its market cap has increased by 4,060.01% in one year.
Market Cap
3.10M
Enterprise Value
n/a
Revenue
42.00K
Global Rank
Country Rank
#6,254 United States
PE Ratio
0.51
ChartMarket Cap Chart
Since December 15, 2006, Affymax's market cap has decreased from 484.83M to 3.10M, a decrease of -99.36%. That is a compound annual growth rate of -22.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 3.10M | 5,100.01% |
| Dec 31, 2025 | 59.59K | - |
| Dec 31, 2024 | 59.59K | 33.33% |
| Dec 29, 2023 | 44.69K | -85.00% |
| Dec 30, 2022 | 297.96K | -33.33% |
| Dec 31, 2021 | 446.94K | -94.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emmaus Life Sciences | 4.10M |
| Pacific Software | 3.12M |
| Vaccinex | 2.69M |
| Bioxytran | 2.67M |
| GPL Holdings | 2.56M |
| Enzolytics | 2.42M |
| Mosaic ImmunoEngineering | 2.41M |
| Abpro Holdings | 2.40M |